Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06348030

Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC

Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage Non-Small Cell Lung Cancer: A Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
St. Joseph's Healthcare Hamilton · Academic / Other
Sex
All
Age
18 Years – 120 Years
Healthy volunteers
Not accepted

Summary

Robotic-assisted thoracoscopic surgery (RTS) is safe and effective for patients with early-stage non-small cell lung cancer (NSCLC). During RTS, division, dissection, and sealing of lung tissue, bronchi, and blood vessels can be performed using handheld staplers with assistance from a bedside surgeon (Surgeon-Assisted), or totally robotically with robotic staplers and energy devices by the console surgeon (Totally Robotic). Totally Robotic lung resection enables the operating surgeon to perform the case independently, but its implication on costs and patient outcomes remains unknown. There also is, however, a lack of prospective research evaluating the costs of the two methods for dissection and vessel sealing in RTS. This RCT aims to evaluate the costs and perioperative patient outcomes of Totally Robotic lung resection using the Vessel Sealer Extend energy device (for vessels \<7mm) and the SureForm robotic stapler (Intervention) versus Surgeon-Assisted robotic lung resection using the Signia stapler (Control) during RTS for NSCLC using the da Vinci system.

Conditions

Interventions

TypeNameDescription
DEVICEMedtronic Signia StaplerThe Signia Stapler is a powered stapler that can be used for tissue dissection and vessel sealing during surgery.
DEVICEVessel Sealer Extend Energy Device and SureForm StaplerThe Vessel Sealer Extend Energy Device is integrated with the da Vinci system and uses bipolar energy technology to facilitate tissue dissection and vessel sealing.

Timeline

Start date
2026-09-01
Primary completion
2028-04-01
Completion
2028-04-01
First posted
2024-04-04
Last updated
2026-02-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06348030. Inclusion in this directory is not an endorsement.